Search

Home > Signal > UPDATE: What happened at the FDA panel review of one Duchenne drug?
Podcast: Signal
Episode:

UPDATE: What happened at the FDA panel review of one Duchenne drug?
Category: Science & Medicine
Duration: 00:08:23
Publish Date: 2015-11-25 11:10:13
Description: An FDA panel reviewed a drug for Duchenne muscular dystrophy called drisaperson on Tuesday. What it found is not encouraging. The Signal podcast takes a look at what happened and where things go from here.
Total Play: 0

Some more Podcasts by Signal

10+ Episodes
Signal